baber/WOPTO huggingface dataset:
Patent JP-H08510067-A (JP)
Title: コンピュータ記憶、ビットマップ制御型静止または動画像をアナログ／デジタル可視化する表示装置
IPC: G09G3/20
Filed: 1994-05-09
Abstract: (57)【要約】
コンピュータ記憶、ビットマップ型の静止または可動パターン、例えばテキスト、イメージ等を少なくとも一つの視覚化媒体（８、8a、15）によってデジタル・アナログ可視化する表示装置において、表示装置が、互いに交差しかつ少なくとも一つの抵抗性及び／又は誘導性スペーサ手段（２）によって互いに離間し、しかも少なくとも一つの制御装置（６）に接続した制御信号を多重化、走査またはパルス化する少なくとも二グループの電極（４、５、18、19）を備えたマトリックス（１）と、これらの電極（４、５、18、19）が制御ユニットからの電気信号に応じて個々にアドレスでき、そして両方のグループの電極のうちの選択した複数の電極が印加されたとき、印加された電極の交点の温度が変化するように配列され、温度変化（熱）が層、本体などのような感熱性示温手段（8a）を含む上記媒休に向かって導かれ、さらに、温度変化を可視ドットまたは同等物に変換する一つまたは複数の表面が形成されている。
Patent JP-2000504886-A (JP)
Title: 音響再生システム
IPC: H04R5/04
Filed: 1997-01-24
Abstract: (57)【要約】
１組のフィルタ（３２）を合成する方法であって、第１及び第２のスピーカー（６６，７２）を第１及び第２の位置にそれぞれ配置し、音響プログラムの第１の成分を前記第１のスピーカー（６６）によって再生すべくこれに接続し、前記音響プログラムの第２の成分を前記第２のスピーカー（７２）によって再生すべくこれに接続する。第１及び第２のマイクロフォンを第３及び第４の位置にそれぞれ配置し、再生された第１及び第２の音響成分がその位置で聞こえるようにして、前記第１及び第２のマイクロフォンに入射した音をそれぞれ第１及び第２のマイクロフォン信号に変換する。前記音響プログラムの第１及び第２の成分と前記第１及び第２のマイクロフォン信号とから、第１の伝達関数セットを生成する。前記第１及び第２の成分と第３及び第４のマイクロフォン信号とからそれぞれ、第２の伝達関数セットを生成する。
Patent JP-2001507137-A (JP)
Title: 多環式ｐ−キノンのペリ−フェノキシ誘導体からの安定蛍光アミンの光化学的発生
IPC: G11B7/244
Filed: 1997-12-12
Abstract: (57)【要約】
本発明は光学記録材料の分野に関する。特に、読み取り専用メモリ（ＲＯＭ）用の三次元光学メモリシステムを含む光学メモリシステムに使用するのに適した蛍光化合物及びマトリックスである。より詳しくは、多環式キノンの非蛍光ペリ−フェノキシ誘導体が、アナキノンの蛍光アミノ誘導体に変換される。
Patent JP-H10503573-A (JP)
Title: 流体およびエラストマーのハイブリッドダンパ
IPC: B64C27/51
Filed: 1995-04-24
Abstract: (57)【要約】
ヘリコプタ・ロータ用のリード‐ラグダンパとして利用される流体およびエラストマーのハイブリッドダンパは、ロータとブレード（翼）のような一対のコンポーネント間の軸方向、ねじれおよび角度的に伝達される振動をエラストマー（２５）のヒステリシスおよび狭い環状通路（４０）を介して流体の絞りおよびシヤリングによって低減する。このハイブリッドダンパはエラストマーおよび流体ダンパの両方の最良の特徴を捕え、各ダンパの欠点の多くを回避する。
Patent JP-H11503502-A (JP)
IPC: E02D5/80
Filed: 1996-04-10
Abstract: Method and arrangement for anchorage in the soil by means of a ground anchor (1) in the form of a tube (2) in which at least two axial slots (3a, 3b) are arranged along at least one region of a tube wall in a part of the tube which is to be driven into the soil. This tube (2) is driven into the soil by cooperating with a pike (4) which is arranged in the tube (2) and which, after the tube has been driven in, is removed therefrom. The method according to the invention is characterized in that the tube (2) in at least one region with axial slots (3a, 3b) is subjected to a radial load by means of a tool (5) which is sunk into the tube and which is actuated so as to exert a controllable expansion of the tube is brought about in this region. The tool is removed from the tube when a predetermined degree of expansion has been attained.
Patent JP-2001509088-A (JP)
IPC: B26B11/00
Filed: 1998-01-28
Abstract: The preferred embodiments described herein relate to a multi-purpose hand-held device. Some of the preferred embodiments describe a multipurpose hand-held implement comprising first and second members connected together to move between a first position, in which they form together an elongated body, and a second position. In one preferred embodiment, a multi-purpose hand-held device is described comprising a stapler and/or punch and other fold-out utensils, wherein a module containing the utensils is preferably incorporated into the stapler-punch component assembly. Other preferred embodiments are described herein.
Patent JP-2001508698-A (JP)
Title: 液体噴霧装置、並びに該装置とともに使用するのに適する使い捨て収納容器およびライナー
IPC: B05B15/06
Filed: 1998-01-14
Abstract: (57)【要約】
スプレーガン(1)は、取外し可能なライナー(13)を収納する流体タンク(11)を備える。該ライナー(13)は、プラスチック材料から熱／真空成形され、前記タンク内部に密接に適合し、前記ガンの作動中に前記ライナーから流体が排出されると崩壊する。前記ライナーは、比較的剛性がある基部を有し、支持されなくても前記タンクの外側で立つことができることが好ましい。前記ライナーの前記側壁は、前記基部に比べて薄く崩壊可能であり、前記ライナーを廃棄できることが好ましい。前記タンク(11)は取外し可能な蓋(15)を有し、逆転させた状態で自立でき、流体を充填することができる。前記蓋(15)は、前記ライナー(13)を前記タンク内に固定する機能も果し、噴霧作業の終わりに、前記蓋(15)および前記ライナー(13)は一緒に前記タンク(11)から取り外して廃棄することができるので、前記スプレーガンの清掃が単純化される。
Patent JP-2000510799-A (JP)
Title: 容器の回転締付封止栓
IPC: B65D41/02
Filed: 1998-02-03
Abstract: (57)【要約】
容器肩部、内容物を取り出す容器ヘッドおよび封止栓キャップから成り、封止栓キャップが回転締付機能を利用して操作される密閉封止ユニットが記載されている。この発明による構想によれば、ネジセグメント（１）が容器肩部（４）に直接続く容器ヘッドの狭い、場合によっては、円筒状の底領域（２）にある。ネジ区域を含む容器ヘッドのこの底領域（２）に取出円錐（３）が続く。この発明の他の構成にとして、封止栓キャップ（５）の蓋板（７）には封止栓キャップ（５）の内部円筒（６）の領域に複数の貫通穴もしくは窓（８）と、ウェブ（９）により保持される封止栓カバー（１０）がある。容器を閉ざした状態で、蓋板（７）の説明した窓（８）を通して、容器ヘッドの取出円錐（３）の端面に中心合わせして固定されたフレッシュシール（１４）の部分を外から目視できる。
Patent JP-2001515347-A (JP)
Title: 肝細胞癌の予防および処置
IPC: A61K38/00
Filed: 1998-02-13
Abstract: (57)【要約】
哺乳動物において、肝細胞癌を含む癌を予防または処置するための方法であって、ここでこの癌は、哺乳動物において、少なくともαフェトプロテイン分子の部分に対する免疫応答を生成することによって、その表面上に少なくともαフェトプロテイン分子の部分を保有する。また、哺乳動物において、少なくともαフェトプロテイン分子の部分に対する免疫応答を生成するための組成物、肝細胞癌を含む癌の予防またはその処置に使用するための組成物であって、この組成物は、少なくともαフェトプロテイン分子の部分を含むか、または１つ以上のアミノ酸が免疫応答を増強するために天然のアミノ酸で置換されている、少なくともαフェトプロテイン分子の部分を含む。
Patent JP-2000517458-A (JP)
IPC: B29C48/09
Filed: 1997-04-29
Abstract: A multi-layer reinforced and stabilized cable construction comprising a core portion (1, 11) and a non-metallic sheathing portion having barrier and protective layers and two or more outer reinforcement layers. In order for the mechanical and barrier properties of the cable to be controlled, the barrier and protective layers and/or the reinforcement layers (12, 13) are oriented in a controlled manner at different angles by fibrous reinforcements or lamellar barriers.
Patent JP-2000509982-A (JP)
Title: 害虫の監視用又は駆除のための方法及び装置
IPC: A01M1/20
Filed: 1997-04-16
Abstract: (57)【要約】
害虫、特にシロアリのようなコロニー内に住みかつ化学的シグナルで通信する有害な社会性昆虫の監視又は駆除のための典型的に地表設置式の方法及び装置が提供される。害虫が食べ得るマトリックス、複数の相互交換可能なハウジング（１２）を備え、各ハウジングは、マトリックス（１６）を保持できる内室（１５）、ハウジングの各を他のハウジングの少なくも１個に着脱可能に連結しこれにより内室をハウジング内に定められた開口を通じて互いに連絡して配置する連結手段、ハウジングの少なくも１個を害虫に近い取付面に取り付ける取付手段を備え、これにより、ハウジングは、マトリックスを比較的限定された空気の動き及び管理された水分蒸発を有する環境内で提供すると同時に、再配列、撤去、補充、及び再取付が可能である。
Patent JP-H11509818-A (JP)
Title: 自動閉鎖式のシール可能な弁バッグ
IPC: B65D30/26
Filed: 1997-05-12
Abstract: (57)【要約】
ここで得られる弁バッグ（８０、８０′）は、フロント側パネル（８２、８２′）から外方へ延びている自動閉鎖式の弁（９２、９２′）を有する。弁（９２、９２′）は、弁スリーブ（９６、９６′）と弁チューブ支持部材（９４、９４′、９５、９５′）とを包含する。弁スリーブ（９６、９６′）および弁チューブ支持部材（９４′、９５′）は弁バッグ（８０、８０′）から外方へ、そしてその内部へ延びている。弁スリーブの内部部分（１０６、１０６′）は材料をバッグに充填した後にバッグの弁（９２、９２′）をシールする。弁（９２、９２′）は、さらに、フロント側パネル（８２、８２′）から外方へ延びる弁スリーブ（９６、９６′）の部分でシールされる。
Patent JP-2000513136-A (JP)
Title: マルチレベル導電性黒色マトリックス
IPC: H01J29/08
Filed: 1998-03-24
Abstract: (57)【要約】
平坦パネルディスプレーデバイスの面板（１０４）上のサブピクセルの横列（１０６，１０８）と縦列（１１０−１２２）を分離するためのマルチレベル導電性マトリックス構造が開示される。このマトリックス構造は一定の高さを有する複数の相互に平行に離間された第１導電性リッジと、この第１導電性リッジの高さより高い高さを有する複数の相互に平行に離間された第２導電性リッジとを有し、これらの第１および第２導電性リッジの交点において第２導電性リッジの高さが第１導電性リッジの高さまで低下する。
Patent JP-2000505925-A (JP)
Title: ピザのような加熱食品を小出しするための機械
IPC: G07F9/10
Filed: 1997-03-26
Abstract: (57)【要約】
この機械は、調理済みの食品（１）を包含する環状の皿（４）が積み重ねられる一連の支柱（３）を備えた冷凍冷蔵貯蔵庫（２）と、回転プラットホーム（５）によって支持され、その下に配置された固定プラットホーム（７）に関して回転することのできる支柱（３）と、１つの支柱（３）の最下部の皿が配置される一連の開口（６）を有する回転プラットホーム（５）とを備え、回転プラットホーム（５）の開口（６）と向かい合う位置において皿（４）が落ち込む開口（１０）を有する摺動プレート（８）が固定プラットホーム（７）と平行に提供され、さらに、摺動プレート（８）がその上を移動することができ、それによって、皿を移動させる下部固定プレート（９）を有し、この下部固定プレート（９）は、さらに、垂直に移動することのできる水平な支持体（１２）を通過させるためのキャビティ（１１）を備え、この支持体（１２）は、オーブン（１４）の中に食品（１）が入り込むまで食品（１）を押し上げる。
Patent JP-2001525823-A (JP)
Title: 抗血栓化合物
IPC: A61K38/00
Filed: 1998-05-07
Abstract: (57)【要約】
本出願は、本明細書中に定義する式（Ｉ）の新規化合物(またはその医薬的に許容され得る塩)、その製造のための方法および中間体、式（Ｉ）の新規化合物を含んでなる医薬品製剤、並びに抗血栓剤としての式（Ｉ）の化合物の使用に関する。
Patent JP-2001526671-A (JP)
IPC: A23L29/00
Filed: 1998-05-14
Abstract: The use is provided of a fructran with an average degree of polymerisation of at least 15 for the manufacture of a composition for the prevention and/or treatment of colon cancer in non-bovine mammals, particularly in human beings. Also provided is a method of prevention and treatment of colon cancer in a non-bovine mammal, particularly in a human being, comprising administering to said mammal a composition comprising an effective dose of a fructan with an average degree of polymerisation of at least 15. The said composition can be a medicament as well as a functional food. In a preferrred embodiment the fructan is inulin, more preferably inulin with an average degree of polymerisation of at least 20.
Patent JP-2001507374-A (JP)
Title: 染毛組成物およびその使用
IPC: A61K8/35
Filed: 1998-05-22
Abstract: (57)【要約】
改良された褪色抵抗性を有する新規な染毛組成物が提供される。この組成物は以下を含有する。（ｉ）酸化され、その後単一求電子作用を受け得るアミノ芳香族系から選択される１つ又はそれ以上の顕色剤；および（ｉｉ）以下の群から選択される１つ又はそれ以上のカップリング剤：（Ａ）ヒドロキシル基に対してパラ位置に活性脱離基を有するフェノールおよびナフトール；（Ｂ）Ｚが活性脱離基である基（Ｉ）を含有する１，３−ジケトン；（Ｃ）Ｚは活性脱離基であり、そしてＸは活性脱離基または非脱離置換基である基（ＩＩ）であり、実質的に活性脱離基Ｚを有する位置でのみ、そしてＸが活性脱離基Ｘである場合には活性脱離基Ｘを有する位置でのみ、そのまたは各カップリング剤と反応するように含有する化合物；を含有する染毛組成物であり、これを毛髪に適用し、２０回洗浄した際、以下のΔＥ褪色値を与える染毛組成物：（ａ）組成物がブロンドまたは明褐色の色合いを与えるのに適している場合、ΔＥ褪色は２．５以下である；（ｂ）組成物が赤色の色合いを与えるのに適している場合、ΔＥ褪色は５．０以下である；（ｃ）組成物が黒色または暗褐色の色合いを与えるのに適している場合、ΔＥ褪色は２．５以下である。
Patent MX-153492-A (MX)
Inventor: DELERIS ROBERT
IPC: F02P5/04
Filed: 1981-06-26
Abstract: An apparatus having a device for measuring speed by counting pulses and a device for measuring pressure by counting pulses wherein a first memory stores advance correction coefficients and a second memory stores a value with respect to full-load advance. An advance counter is connected to the outputs of the second memory and to the highest-weight output of the pressure counter by way of a series connection of a binary rate multiplier, a divider which divides by M and a switching device.
Patent MX-161338-A (MX)
Inventor: VALKIRS GUNARS EDWIN
IPC: C12M1/00
Filed: 1985-05-13
Abstract: Disclosed herein is an apparatus and process for conducting ligand receptor assays. The apparatus comprises a first member which is a membrane or a filter to which is bound a receptor for the ligand or which is capable of extracting cells carrying the ligand from a fluid sample. The apparatus further comprises a second member which is composed of absorbent material which acts when in contact with the first member to induce flow through the first member when a fluid sample is added to it. The apparatus is used to conduct assays by applying a sample to the upper surface of the first member to bind ligand in the sample by means of receptor fixed to the first member or, in certain cases, by extracting cellular material which has ligand associated with it. Addition of the sample is typically followed by addition of labeled antibody against the antigen being assayed followed by a washing step to remove unbound labeled receptor. The presence of labeled antibody on the first member after washing is indicative of the presence of the antigen in the sample being assayed. In a preferred embodiment of the invention, the ligand is an antigen and the receptor is an antibody.
Patent NZ-191641-A (NZ)
Title: Oil-soluble anti-wear additive containing benzotriazole/tricresyl phosphate reaction product
Inventor: POOLE R
IPC: C10N50/10
Filed: 1979-09-24
Abstract: This invention relates to novel antiwear additive comprising the reaction product of benzotriazole and tricresyl phosphate and the combination of calcium dinonyl naphthalene sulfonate and calcium alkyl phenate and oleaginous compositions containing this additive. Such compositions are thus provided with good control, rust protection and improved cleanliness plus antiwear protection.
Patent NZ-191827-A (NZ)
Title: Prostacyclin derivatives and pharmaceutical compositions
Inventor: VORBRUGGEN H
IPC: A61K31/557
Filed: 1979-10-19
Abstract: Compounds of the formula   <IMAGE>   wherein R1 is (a) hydrogen, (b) C1-10 alkyl, (c) C1-10 alkyl substituted by halogen; C1-4 alkoxy; C6-10 aryl; C6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C1-4 alkoxy group; di-C1-4-alkylamino; or tri-C1-4-alkylammonium, (d) C4-10 cycloalkyl, (e) C4-10 cycloalkyl substituted by C1-4 alkyl, (f) C6-10 aryl, (g) C6-10 aryl substituted by 1-3 halogen atoms, a phenyl group 1-3 C1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C1-4 alkoxy group, or (h) an aromatic heterocycle of 5 or 6 ring atoms one of which is O, N or S; A is -CH2-CH2-, trans-CH=CH- or -C 3BOND C-; W is hydroxymethylene, RO-methylene, CH3 or CH3,   <IMAGE>   wherein OH or OR is in the  alpha - or  beta -position and R is an in vivo hydrolyzable and physiologically acceptable ether or acyl group which is conventional for modifying OH groups in prostaglandins; D and E together are a direct bond, or D is C1-10 alkylene, C1-10 alkenylene or C1-10 alkynylene or one of these groups substituted by fluorine, and E is oxygen, -C 3BOND C- or a direct bond; R2 is (a) a C1-10 hydrocarbon aliphatic radical, (b) a C6-10 hydrocarbon aliphatic radical substituted by C6-10 aryl or by C6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C1-4 alkoxy group; (c) C4-10 cycloalkyl, (d) C4-10 cycloalkyl substituted by C1-4 alkyl, (e) C6-10 aryl, (f) C6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C1-4 alkoxy group; or (h) an aromatic heterocycle of 5 or 6 ring atoms one of which is O, N or S; and R3 is OH or OR; and, when R1 is hydrogen, the salts thereof with physiologically compatible bases, are effective as antihypertensive, bronchiodilators, thrombocyte aggregation inhibitors, inter alia.
Patent NZ-214565-A (NZ)
Title: Oxetanone derivatives and pharmaceutical compositions
Inventor: BARBIER P
IPC: A61K31/335
Filed: 1985-12-16
Abstract: Oxetanones of formula (I) and their salts with weak acids are new: R1 and R2 = 1-17C alkyl (opt. having up to 8 double or triple bonds and opt. interrupted by an O or S atom which is not alpha to an unsatd. C atom), phenyl, benzyl or -C6H4-X-C6H5, all opt. ring-substd. by 1-3 1-6C alkyl, alkoxy or alkylthio; X = O, S or (CH2)m; m = 0-3; R3 = H or 1-3C alkyl or alkanoyl; R4 = H or 1-3C alkyl; R5 = H, Ar or Ar-(1-3C) alkyl or is 1-7C alkyl, opt. interrupted by Y and/or substd. by Z; or R4 and R5 together make a 4-6 membered satd. ring; Y = O, S, NR6, CONR6 or NR6.CO; Z = OR7, SR7, NR7R8, CONR7R8 or NR7.COR8; n = 0 or 1, and if 1 then R5 = H; Ar = phenyl, opt. substd. by up to 3 R9 or ORa; R6, R7, R8 and R9 = H or 1-3C alkyl. Where R3 = HCO and R5 = isobutyl, or R3 = MeCO and R5 = carbamoylethyl and also R2 = undecyl or 2,5-undecadienyl and R1 = n-hexyl, then R4 is not H. Also new are ethanol derivs. (III): when R1 = n -hexyl and R2 = undecyl or 2Z,5Z-undecadienyl, at least one asymmetric C atom in the ring or in beta-position to the ring has the R configuration. -
Patent NZ-217829-A (NZ)
Title: Monoclonal anti-human breast cancer antibodies and test reagent
Inventor: RING D B
IPC: C12P21/00
Filed: 1986-10-07
Abstract: Hybridomas producing monoclonal antibodies suitable for imaging and diagnosis of human breast tumors and such monoclonal antibodies are claimed. The monoclonals are characterized by breast tumor binding range, breast cancer cell line range, and selectively.immunoimaging agents comprising the monoclonal antibody and a detectable label, either directly or indirectly conjugated to the antibody are claimed. Methods for imaging breat tumors using the immunoimaging agents are described and claimed.
Patent NZ-224519-A (NZ)
Title: Particle-amplified immunological assay using antiserum to reduce non specific agglutination
Inventor: KAPMEYER WOLFGANG
IPC: G01N33/546
Filed: 1988-05-06
Abstract: The method for detecting or determining a participant in a particle-enhanced immunological reaction by a nephelometric, turbidimetric or particle-counting method comprises carrying out the detection or determination in the presence of an antiserum which contains no antibodies which are specific for one of the immunological reactants.
Patent NZ-232776-A (NZ)
Title: Carpet cutting guide
Inventor: WARD JONATHAN
IPC: B26B29/00
Filed: 1990-03-05
Abstract: PCT No. PCT/GB90/00334 Sec. 371 Date Jun. 1, 1992 Sec. 102(e) Date Jun. 1, 1992 PCT Filed Mar. 5, 1990 PCT Pub. No. WO90/10526 PCT Pub. Date Sep. 20, 1990.A guide for use in cutting carpet and a method of joining two portions of cut carpet in edge-to-edge relationship has a base formed as a lower portion and an upper portion interengaged through a longitudinal slideway and presenting an upper ramp surface. The upper portion has a longitudinal channel along which a knife blade can pass to cut a carpet portion laid on the ramp. The lower portion has a vertical wall vertically below the channel and against which the cut edge of first carpet portion is located to abut during cutting of the second carpet portion on the ramp so that when the guide is removed the two cut edges will fall into edge-to-edge abutment for joining together.
Patent NZ-242156-A (NZ)
Title: Diagnostic imaging reagent having at least two metal atoms and a non-metal bridging group
Inventor: ALMEN TORSTEN
IPC: C07F15/00
Filed: 1992-03-27
Abstract: PCT No. PCT/EP92/00698 Sec. 371 Date Sep. 24, 1993 Sec. 102(e) Date Nov. 24, 1993 PCT Filed Mar. 27, 1992 PCT Pub. No. WO92/17215 PCT Pub. Date Oct. 15, 1992.An imaging contrast medium comprising a physiologically tolerable multinuclear complex (as defined in claim 1) is disclosed. The multinuclear complex contains at least two, but preferably three or more contrast enhancing atoms. For X-ray or ultrasound imaging techniques heavy metal atoms are used to enhance contrast, whereas in Magnetic Resonance Imaging paramagnetic metal atoms are contrast enhancing. Molybdenum and tungsten are preferred contrast enhancing atoms. The medium may also be used therapeutically.
Patent NZ-272081-A (NZ)
Title: 8-amino-10-(azabicycloalkyl)-pyrido[1,2,3-de][1,2,3]benzodoxadiazine derivatives and pharmaceutical compositions containing such compounds
Inventor: JAETSCH THOMAS
IPC: C07D498/06
Filed: 1995-05-08
Abstract: 8-Amino-10-azabicycloalkyl-pyrido(1,2,3-de) (1,3,4)benzoxadiazine derivs. of formula (I) are new: R<1> = H or 1-4C alkyl opt. substd. by OH or halo; R<2> = H or Me; R<3> = H or 1-4C alkyl; R<4> = H; 1-4C alkyl opt. substd. by OH, OMe, amino, etc.; X<1> = H or halo; Z = a gp. of formula (i)-(iii); R<7> = H, OH, NR<10>R<11>, etc.; R<10> = H, 1-3C alkyl, etc.; R<11> = H or Me; R<8> = e.g. H ; R<6>, R<9> = H or Me; R<5> = H, Me, CH=CHCOOR<5>', etc.; R<5>' = Me or Et; and B = CH2, O or a direct bond.
Patent NZ-309241-A (NZ)
Title: Crossing network utilizing satisfaction density profile
Inventor: LUPIEN WILLIAM A
IPC: G06Q30/02
Filed: 1996-04-26
Abstract: PCT No. PCT/US96/07265 Sec. 371 Date Oct. 21, 1997 Sec. 102(e) Date Oct. 21, 1997 PCT Filed Apr. 26, 1996 PCT Pub. No. WO96/34357 PCT Pub. Date Oct. 31, 1996A crossing network that matches buy and sell orders based upon a satisfaction and quantity profile is disclosed. The crossing network includes a number of trader terminals that can be used for entering order. The orders are entered in the form of a satisfaction density profile that represents a degree of satisfaction to trade a particular instrument at various (price, quantity) combinations. Typically, each order is either a buy order or a sell order. The trader terminals are coupled to a matching controller computer. The matching controller computer can receive as input the satisfaction density profiles entered at each one of the trading terminals. The matching controller computer matches orders (as represented by each trader's satisfaction density profile) so that each trader is assured that the overall outcome of the process (in terms of average price and size of fill) has maximized the mutual satisfaction of all traders. Typically, the matching process is anonymous. The matching process can be continuous or a batch process, or a hybrid of the two. Unmatched satisfaction density profiles can be used to provide spread and pricing information. Factors other than price and quantity also may be used to determine the degree of satisfaction. Optionally, priority may be given to certain profiles in the matching process to accommodate stock exchange rules, for example, requiring that priority be given to orders exhibiting the best price, regardless of size or any other consideration. The crossing network has utility both in the securities industry and for non-securities industry applications.
Patent NZ-331466-A (NZ)
Title: Fused-ring carboxylic acid derivatives
Inventor: TAGAMI KATSUYA
IPC: C07C69/94
Filed: 1997-03-18
Abstract: These fused-ring carboxylic acid derivatives, which are useful for preparing  pharmaceutical compositions as retinoic acid receptor agonists, are represented by general formula (A) and pharmacologically acceptable salts thereof, where the dotted dash lines represent a single or double bond; and each of X, Y, Z, P, Q, U, V and W represents -O-, -S- or a group represented by formula (a), where Rk represents hydrogen, halogeno, optionally substituted  alkyl, etc., and either R7 or R8 represents a group represented by formula (b), wherein rings A and B represent each independently an optionally substituted aromatic hydrocarbon or unsaturated heterocyclic ring; and D represents an optionally protected carboxyl group.
Patent NZ-333780-A (NZ)
Title: Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases
Inventor: AUDONNET JEAN-CHRISTOPHE
IPC: C12N15/45
Filed: 1997-07-15
Abstract: A vaccine formula for treating dog diseases including at least two vaccine valencies that each include a plasmid containing the canine pathogens of Carre's disease virus (CDV) and canine parvovirus (CPV).  The plasmids include one or more genes per valency, selected from the group of HA and F for CDV, and VP2 for CPV.   The vaccine formula may further comprise one or more valencies selected from the group of the S and M genes of canine coronavirus, the gB and gD genes of herpesvirosis CHV, the OspA, OspB and p100 genes for Lyme disease and the g gene for rabies.
Patent NZ-334445-A (NZ)
Title: Organic liquid nutrition source for plants from animal-derived raw material and manufacturing method for same
Inventor: KAWAMOTO HIDEKATSU
IPC: C05F1/00
Filed: 1999-03-02
Abstract: This organic liquid fertilizer comprises a liquid mixture of a: animal-derived raw materials (which has been decomposed and separated into a first liquid containing primarily fatty acids and a second liquid containing primarily soluble protein to which a surfactant has been added) and b: a sugar-containing liquid: which are mixed and agitated.
Patent NZ-337479-A (NZ)
Title: Inhaler including a dose mechanism for providing a dose of powder and a rotatable member
Inventor: ANDERSSON JAN
IPC: A61M15/00
Filed: 1998-03-13
Abstract: An inhaler is disclosed for administration powder by inhalation, comprising: a flow path defined by a plurality of surfaces through which a stream of air is in used drawn on inhalation by a user, the flow path including a mouthpiece (2); and dosing means for providing a dose of powder to the flow path for entrainment in the stream of air; characterized in that the inhaler further comprises a movable member downstream of the dosing means for inhibiting accumulation of powder on a surface of the flow path downstream of the dosing means.
Patent NZ-504384-A (NZ)
Title: One piece U - shaped shell structure for toaster, with open end of U in front panel
Inventor: GUREVICH LEON
IPC: A47J37/08
Filed: 2000-05-08
Abstract: A shell for a toaster is made from a single piece of metal formed into a U shape.  The shell has side panels 302, 304, and a rear panel 306.  The front of the shell consists of two sub-panels 316, 318 separated by a gap 320.  This gap allows components of the toaster to be inserted into the shell during construction.  Apertures 319, 321, in the sub panels receive terminals of the heating elements.  Hooks 324, 325 receive a portion of a bread guard.  The side panels have slotted flanges 310 which receive tabs from corresponding heating elements.  A center heating element is attached to tab 326 on rear panel 306.  This shell construction is stated to facilitate the automated assembly of the toaster.